Target intelligence / Profile preview

Automated basal and bolus insulin adjustment based on continuous interstitial glucose measurement (AID system)

Target
AID system
Molecular classification
Other (medical device/algorithmic therapy, not a molecular target)
01

Overview

The entry "Automated basal and bolus insulin adjustment based on continuous interstitial glucose measurement" does **not** refer to a single molecule, receptor, enzyme, transporter, or other canonical therapeutic target. Instead, it describes an **integrated medical technology**—commonly known as an automated insulin delivery (AID) system or hybrid closed-loop system—that combines three main components: * A **continuous glucose monitor** (CGM), which measures interstitial fluid glucose levels in real time. * An **insulin pump**, which delivers both basal and bolus doses of subcutaneous insulin. * A **control algorithm**, which processes CGM data to automatically adjust the rate of basal and sometimes correctional bolus insulin delivered by the pump[1][2][3][5]. These systems are designed to mimic some functions of the healthy pancreas ("artificial pancreas") by automating much of the day-to-day decision-making required for intensive diabetes management. They are primarily used for people with type 1 diabetes but have also shown benefit in type 2 diabetes requiring intensive therapy[4]. The user typically still needs to manually enter carbohydrate intake before meals; fully automated systems without any manual input are not yet standard. Because this is a description of a *device-based therapeutic approach*, not a molecular entity or biological target amenable to drug binding/modulation, it should be flagged as "not a target" per your conventions. If you need structured information about specific molecules involved—such as the human *insulin receptor*, *GLUT transporters*, etc.—please specify those targets instead.

Other names
Automated insulin delivery systemHybrid closed-loop systemArtificial pancreasAutomated insulin dosing (AID) systemClosed-loop insulin delivery system
02

Mechanism of action

Algorithm-driven adjustment of basal and bolus insulin delivery based on continuous interstitial glucose measurements from a CGM[1][2][5].

03

Biological functions

Glucose regulation in diabetes managementInsulin dose adjustment based on real-time glucose monitoring
04

Disease associations

Diabetes mellitus (Type 1 and Type 2)Other (used for glycemic control in insulin-dependent diabetes)
05

Safety considerations

Risk of hypoglycemia or hyperglycemia if device malfunctions or settings are incorrect[6]Potential for user error during manual bolus dosing or meal input[6]
06

Interacting drugs

Insulin (various formulations used in pumps, e.g., rapid acting insulins like insulin aspart, lispro, glulisine)
07

Biomarkers

Interstitial glucose concentration measured by continuous glucose monitor (CGM)[1][8]

Beyond the preview

Go deeper on Automated basal and bolus insulin adjustment based on continuous interstitial glucose measurement (AID system).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Automated basal and bolus insulin adjustment based on continuous interstitial glucose measurement (AID system).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call